Current and future use of umifenovir in patients with COVID-19

At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the "experimental" nature of this treatment.

Saved in:
Bibliographic Details
Main Authors: Yu. Yu. Kiselev (Author), K. A. Zagorodnikova (Author), D. V. Ivashchenko (Author), A. V. Krykov (Author), I. N. Sychev (Author), A. S. Matveev (Author), K. B. Mirzaev (Author), V. A. Otdelenov (Author), V. M. Tsvetov (Author), A. V. Dmitriev (Author), V. V. Poroikov (Author), D. A. Sychev (Author)
Format: Book
Published: Izdatelstvo OKI, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the "experimental" nature of this treatment.
Item Description:2588-0519
2618-8473
10.37489/2588-0519-2020-S4-75-80